|

Higher vs. Lower Dose Heparin for PCI

RECRUITINGN/ASponsored by Population Health Research Institute
Actively Recruiting
PhaseN/A
SponsorPopulation Health Research Institute
Started2022-03-02
Est. completion2024-10-08
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04049591

Summary

HD PCI is a multicenter, randomized, registry-based, cluster crossover design trial of higher dose versus lower dose heparin in patients undergoing elective percutaneous coronary intervention (PCI).

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

\- Patients undergoing elective PCI

Exclusion Criteria:

* Age \<18 years
* Planned chronic total occlusion PCI
* Non-resident precluding follow up through local registries

Hospital (Cluster) Eligibility Criteria

Hospitals will be eligible to participate if they meet the following criteria:

* Submit PCI procedure data to a compatible registry that is able to provide data for the trial
* Site agrees to manage patients as per the higher or lower dose heparin policy in place during the given crossover period

Conditions3

Cardiovascular DiseasesHeart DiseasePercutaneous Coronary Intervention

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.